This inventor holds 3 USPTO granted patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2002-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brugge, BE (2002)
- Bruges, BE (2007)
- Brugge 2, BE (2011)
Company Filing History:
Years Active: 2002-2011
Title: The Innovations of Lieven Baert
Introduction
Lieven Baert is a notable inventor based in Bruges, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compositions. With a total of 3 patents to his name, Baert's work is recognized for its potential impact on treating viral infections.
Latest Patents
Baert's latest patents focus on pharmaceutical compositions that contain antiviral compounds. These compositions are designed to be administered to mammals, especially humans, suffering from viral infections. The innovative aspect of his work involves the creation of particles that are obtained by melt-extruding a mixture of antiviral compounds and appropriate water-soluble polymers, followed by milling the melt-extruded mixture. This method enhances the effectiveness of the antiviral treatments.
Career Highlights
Lieven Baert is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His role at the company allows him to leverage his expertise in developing advanced therapeutic solutions. Baert's dedication to innovation in pharmaceuticals has positioned him as a key figure in the fight against viral diseases.
Collaborations
Baert collaborates with Geert Verreck, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in advancing pharmaceutical research and development.
Conclusion
Lieven Baert's contributions to antiviral compositions highlight his commitment to improving healthcare through innovation. His work at Janssen Pharmaceutica NV and his patented inventions are paving the way for more effective treatments against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
